Driven by GLP-1 shortages and FDA compounding restrictions, a multi-billion-dollar gray market for injectable peptides ...
Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA’s bulks ...
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and ...
An audit of state Medicaid records revealed how PBMs are using complicated tactics for handling prescription drug claims that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results